---
figid: PMC7567033__fonc-10-572904-g0001
figtitle: Scheme of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian
  target of rapamycin (mTOR) pathway in the regulation of autophagy process
organisms:
- Curcuma longa
- Magnolia officinalis
- Homo sapiens
- Rattus norvegicus
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC7567033
filename: fonc-10-572904-g0001.jpg
figlink: pmc/articles/PMC7567033/figure/F1/
number: F1
caption: 'Scheme of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian
  target of rapamycin (mTOR) pathway in the regulation of autophagy process. The PI3K/AKT/mTOR
  signaling pathway is activated by various receptor tyrosine kinases (RTKs), such
  as epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor
  (VEGFR), and platelet-derived growth factor receptor (PDGFR), while the pathway
  is negatively regulated by phosphatase and tensin homolog (PTEN). Hyperactivation
  of the PI3K/AKT/mTOR pathway inhibits autophagy, and suppression of the PI3K/AKT/mTOR
  pathway induces autophagy. mTOR complex I (mTORC1) plays a key role in the regulation
  of autophagy process. Under conditions of nutrient sufficiency, mTORC1 is activated
  and inhibits autophagy. Under starvation or low energy, AMP-activated protein kinase
  (AMPK) is activated and mTORC1 is inactivated, leading to the initiation of autophagy.
  Induction of autophagy can be summarized into several phases: initiation, nucleation,
  elongation, maturation, fusion, and degradation. Autophagy has a dual role in pro-survival
  or pro-cell death in GB progression. NF1, neurofibromin 1; PIP2, phosphatidylinositol-4,5-bisphosphate;
  PIP3, phosphatidylinositol-3,4,5-trisphosphate; PDK1, 3-phosphoinositide-dependent
  kinase-1; TSC1/2, tuberous sclerosis complex 1/2; RHEB, Ras homolog enriched in
  brain; LKB1, liver kinase B1; p70S6K, 70-kDa ribosomal protein S6 kinase; EIF4EBP1,
  eukaryotic translation initiation factor 4E-binding protein 1.'
papertitle: Therapeutic Potential of Autophagy in Glioblastoma Treatment With Phosphoinositide
  3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin Signaling Pathway Inhibitors.
reftext: Qin Xia, et al. Front Oncol. 2020;10:572904.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9030272
figid_alias: PMC7567033__F1
figtype: Figure
redirect_from: /figures/PMC7567033__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7567033__fonc-10-572904-g0001.html
  '@type': Dataset
  description: 'Scheme of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian
    target of rapamycin (mTOR) pathway in the regulation of autophagy process. The
    PI3K/AKT/mTOR signaling pathway is activated by various receptor tyrosine kinases
    (RTKs), such as epidermal growth factor receptor (EGFR), vascular endothelial
    growth factor receptor (VEGFR), and platelet-derived growth factor receptor (PDGFR),
    while the pathway is negatively regulated by phosphatase and tensin homolog (PTEN).
    Hyperactivation of the PI3K/AKT/mTOR pathway inhibits autophagy, and suppression
    of the PI3K/AKT/mTOR pathway induces autophagy. mTOR complex I (mTORC1) plays
    a key role in the regulation of autophagy process. Under conditions of nutrient
    sufficiency, mTORC1 is activated and inhibits autophagy. Under starvation or low
    energy, AMP-activated protein kinase (AMPK) is activated and mTORC1 is inactivated,
    leading to the initiation of autophagy. Induction of autophagy can be summarized
    into several phases: initiation, nucleation, elongation, maturation, fusion, and
    degradation. Autophagy has a dual role in pro-survival or pro-cell death in GB
    progression. NF1, neurofibromin 1; PIP2, phosphatidylinositol-4,5-bisphosphate;
    PIP3, phosphatidylinositol-3,4,5-trisphosphate; PDK1, 3-phosphoinositide-dependent
    kinase-1; TSC1/2, tuberous sclerosis complex 1/2; RHEB, Ras homolog enriched in
    brain; LKB1, liver kinase B1; p70S6K, 70-kDa ribosomal protein S6 kinase; EIF4EBP1,
    eukaryotic translation initiation factor 4E-binding protein 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRB
  - PDGFRA
  - EGFR
  - KDR
  - FLT1
  - FLT4
  - NF1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - ATP8A2
  - APRT
  - MFAP1
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - STK11
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TSC1
  - CCL26
  - TSC2
  - TP53
  - RHEB
  - RHEBP1
  - ULK1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - RB1CC1
  - ATG13
  - RPTOR
  - ATG101
  - DEPTOR
  - BCL2
  - RPS6KB1
  - RPS6KB2
  - EIF4EBP1
  - AMBRA1
  - SH3GLB1
  - BECN1
  - UVRAG
  - ATG14
  - PIK3C3
  - SUCLG2
  - GNB1
  - GNB2
  - GNB3
  - GNB4
  - GNB5
  - Egfr
  - Nf1
  - Pik3cg
  - Pten
  - Tmprss5
  - Pdk1
  - Akt1
  - Stk11
  - Prkaa2
  - Tsc1
  - Tsc2
  - Tp53
  - Rheb
  - Ulk1
  - Atg13
  - Atg101
  - Deptor
  - Bcl2
  - Bcl2l1
  - Eif4ebp1
  - Ambra1
  - Becn1
  - Uvrag
  - Atg14
  - ti
  - Pvr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ATPsynbeta
  - Atpalpha
  - Amph
  - Akt
  - Lkb1
  - SNF4Agamma
  - AMPKalpha
  - gig
  - Atg1
  - Atg17
  - Crtc
  - Debcl
  - S6k
  - Atg6
  - gb
  - Gbeta5
  - Gbeta13F
  - Gbeta76C
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
